Copyright
©The Author(s) 2022.
World J Gastroenterol. Oct 28, 2022; 28(40): 5827-5844
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5827
Published online Oct 28, 2022. doi: 10.3748/wjg.v28.i40.5827
Stage | TNM | Description |
0 | Tis | Carcinoma in situ1 |
N0 | No regional lymph node metastases | |
M0 | No distant metastasis | |
IA | T1 | T1 = Tumor is ≤ 2 cm in any direction |
T1a = Tumor is ≤ 0.5 cm in any direction | ||
T1b = Tumor is > 0.5 cm and < 1 cm in any direction | ||
T1c = Tumor is 1–2 cm in any direction | ||
N0 | No regional lymph node metastases | |
M0 | No distant metastasis | |
IB | T2 | Tumor is > 2 cm and ≤ 4 cm in any direction |
N0 | No regional lymph node metastases | |
M0 | No distant metastasis | |
IIA | T3 | Tumor is > 4 cm in any direction |
N0 | No regional lymph node metastases | |
M0 | No distant metastasis | |
IIB | T1 | T1 = Tumor is ≤ 2 cm in any direction |
T1a = Tumor is ≤ 0.5 cm in any direction | ||
T1b = Tumor is > 0.5 cm and < 1 cm in any direction | ||
T1c = Tumor is 1–2 cm in any direction | ||
N1 | Metastasis in one to three regional lymph nodes | |
M0 | No distant metastasis | |
T2 | Tumor is > 2 cm and ≤ 4 cm in any direction | |
N1 | Metastasis in one to three regional lymph nodes | |
M0 | No distant metastasis | |
T3 | Tumor is > 4 cm in any direction | |
N1 | Metastasis in one to three regional lymph nodes | |
M0 | No distant metastasis | |
III | T1 | T1 = Tumor is ≤ 2 cm in any direction |
T1a = Tumor is ≤ 0.5 cm in any direction | ||
T1b = Tumor is > 0.5 cm and < 1 cm in any direction | ||
T1c = Tumor is 1–2 cm in any direction | ||
N2 | Metastasis in four or more regional lymph nodes | |
M0 | No distant metastasis | |
T2 | Tumor is > 2 cm and ≤ 4 cm in any direction | |
N2 | Metastasis in four or more regional lymph nodes | |
M0 | No distant metastasis | |
T3 | Tumor is > 4 cm in any direction | |
N2 | Metastasis in four or more regional lymph nodes | |
M0 | No distant metastasis | |
T4 | Regardless of tumor size, the cancer has grown outside the pancreas, into the nearby large blood vessels2 | |
Any N | NX = Regional lymph nodes cannot be assessed | |
N0 = No regional lymph node metastases | ||
N1 = Metastasis in one to three regional lymph nodes | ||
N2 = Metastasis in four or more regional lymph nodes | ||
M0 | No distant metastasis | |
IV | Any T | TX = Primary tumor cannot be assessed |
T0 = No evidence of primary tumor | ||
Tis = Carcinoma in situ1 | ||
T1 = Tumor is ≤ 2 cm in any direction | ||
T1a = Tumor is ≤ 0.5 cm in any direction | ||
T1b = Tumor is > 0.5 cm and < 1 cm in any direction | ||
T1c = Tumor is 1–2 cm in any direction | ||
T2 = Tumor is > 2 cm and ≤ 4 cm in any direction | ||
T3 = Tumor is > 4 cm in any direction | ||
T4 = Regardless of tumor size, the cancer has grown outside the pancreas, into the nearby large blood vessels2 | ||
Any N | NX = Regional lymph nodes cannot be assessed | |
N0 = No regional lymph node metastases | ||
N1 = Metastasis in one to three regional lymph nodes | ||
N2 = Metastasis in four or more regional lymph nodes | ||
M1 | Distant metastasis |
- Citation: Calimano-Ramirez LF, Daoud T, Gopireddy DR, Morani AC, Waters R, Gumus K, Klekers AR, Bhosale PR, Virarkar MK. Pancreatic acinar cell carcinoma: A comprehensive review. World J Gastroenterol 2022; 28(40): 5827-5844
- URL: https://www.wjgnet.com/1007-9327/full/v28/i40/5827.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i40.5827